Adaptimmune Therapeutics plc financial statements, including revenue, expenses, profit, and loss

The total revenue of ADAP for the last quarter is 233.01 k USD, and it's 96.80% lower compared to the previous quarter. The net income of Q4 23 is -48.33 M USD.